Intervention

Rifapentine (RPT)

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions8

Lead sponsors shown2

Clinical trials

3 shown

Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected IndividualsNCT04272242 · 2021-02-27

Doravirine, Rifapentine and Isoniazid InteractionNCT03886701 · 2019-04-22

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)NCT01404312 · 2012-05-23

Common conditions

Drug Interaction Potentiation1 HIV Infection1 HIV Infections1 Human Immunodeficiency Virus1 Latent Tuberculosis1 LTBI1 Rifamycins Causing Adverse Effects in Therapeutic Use1 Tuberculosis1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)2 Walter K. Kraft1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.